199 related articles for article (PubMed ID: 15107210)
1. Managing the menopause: BMS Council Consensus statement on HRT.
Pitkin J; Rees MC; Gray S; Lumsden MA; Marsden J; Stevenson J; Williamson J;
J Br Menopause Soc; 2004 Mar; 10(1):33-6. PubMed ID: 15107210
[TBL] [Abstract][Full Text] [Related]
2. Managing the menopause - British Menopause Society Council consensus statement on hormone replacement therapy.
Pitkin J; Rees MC; Gray S; Lumsden MA; Stevenson J; Williamson J;
J Br Menopause Soc; 2003 Sep; 9(3):129-31. PubMed ID: 14670199
[TBL] [Abstract][Full Text] [Related]
3. Managing the menopause: British Menopause Society Council consensus statement on hormone replacement therapy.
Pitkin J; Rees MC; Gray S; Lumsden MA; Marsden J; Stevenson J; Williamson J;
J Br Menopause Soc; 2005 Dec; 11(4):152-6. PubMed ID: 16354459
[TBL] [Abstract][Full Text] [Related]
4. The 2017 hormone therapy position statement of The North American Menopause Society.
Menopause; 2018 Nov; 25(11):1362-1387. PubMed ID: 30358733
[TBL] [Abstract][Full Text] [Related]
5. Impact of women's health initiative study on attitude and acceptance of hormone replacement therapy in Thai women attending menopause clinics.
Chaikittisilpa S; Jirapinyo M; Chaovisitsaree S; Wipatavit V; Bunyaviroch S; Kanluan B; Panyakhamlerd K; Jaisamrarn U; Taechakraichana N
J Med Assoc Thai; 2007 Apr; 90(4):628-35. PubMed ID: 17487115
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
7. The 2017 hormone therapy position statement of The North American Menopause Society.
The NAMS 2017 Hormone Therapy Position Statement Advisory Panel
Menopause; 2017 Jul; 24(7):728-753. PubMed ID: 28650869
[TBL] [Abstract][Full Text] [Related]
8. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
9. Urogenital atrophy.
Pitkin J; Rees M;
Menopause Int; 2008 Sep; 14(3):136-7. PubMed ID: 18714081
[TBL] [Abstract][Full Text] [Related]
10. Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2003; 10(2):113-32. PubMed ID: 12627037
[TBL] [Abstract][Full Text] [Related]
11. Alternatives for optimal hormone replacement therapy.
Sitruk-Ware R
Climacteric; 2003 Aug; 6 Suppl 2():11-6. PubMed ID: 14669839
[TBL] [Abstract][Full Text] [Related]
12. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
Lemay A
J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
[TBL] [Abstract][Full Text] [Related]
13. Japan Society of Obstetrics and Gynecology and Japan Society for Menopause and Women's Health 2017 guidelines for hormone replacement therapy.
Okano H; Higuchi T; Kurabayashi T; Makita K; Mizunuma H; Mochizuki Y; Obayashi S; Yasui T; Takamatsu K;
J Obstet Gynaecol Res; 2018 Aug; 44(8):1355-1368. PubMed ID: 29957860
[TBL] [Abstract][Full Text] [Related]
14. Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause.
Lobo RA; Pickar JH; Stevenson JC; Mack WJ; Hodis HN
Atherosclerosis; 2016 Nov; 254():282-290. PubMed ID: 27745704
[TBL] [Abstract][Full Text] [Related]
15. Achieving long-term continuance of menopausal ERT/HRT: consensus opinion of the North American Menopause Society.
Menopause; 1998; 5(2):69-76. PubMed ID: 9689198
[TBL] [Abstract][Full Text] [Related]
16. Recent concerns surrounding HRT.
Armitage M; Nooney J; Evans S
Clin Endocrinol (Oxf); 2003 Aug; 59(2):145-55. PubMed ID: 12864790
[TBL] [Abstract][Full Text] [Related]
17. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
18. The evidence base for HRT: what can we believe?
Langer RD
Climacteric; 2017 Apr; 20(2):91-96. PubMed ID: 28281363
[TBL] [Abstract][Full Text] [Related]
19. Perspectives on the Women's Health Initiative trial of hormone replacement therapy.
Grimes DA; Lobo RA
Obstet Gynecol; 2002 Dec; 100(6):1344-53. PubMed ID: 12468183
[TBL] [Abstract][Full Text] [Related]
20. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
